Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

ClinicalTrials.gov ID: NCT01114217

Public ClinicalTrials.gov record NCT01114217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Study identification

NCT ID
NCT01114217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
634 participants

Conditions and interventions

Interventions

  • Ferumoxytol Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2010
Primary completion
Sep 23, 2012
Completion
Apr 22, 2013
Last update posted
Apr 20, 2022

2010 – 2013

United States locations

U.S. sites
103
U.S. states
26
U.S. cities
79
Facility City State ZIP Site status
Clinical Trial Site Birmingham Alabama
Clinical Trial Site Mobile Alabama
Clinical Trial Site Montgomery Alabama 36106
Clinical Trial Site Montgomery Alabama 36116
Clinical Trial Site Phoenix Arizona 85015
Clinical Trial Site Phoenix Arizona 85032
Clinical Trial Site Tucson Arizona 85710
Clinical Trial Site Tucson Arizona 85712
Clinical Trial Site Anaheim California
Clinical Trial Site Bakersfield California
Clinical Trial Site Buena Park California
Clinical Trial Site Colton California
Clinical Trial Site Los Angeles California 90036
Clinical Trial Site Los Angeles California 90057
Clinical Trial Site Los Angeles California
Clinical Trial Site Mission Hills California
Clinical Trial Site Orange California
Clinical Trial Site San Diego California 92103
Clinical Trial Site San Diego California 92121
Clinical Trial Site San Diego California 92123
Clinical Trial Site Pueblo Colorado
Clinical Trial Site Bristol Connecticut
Clinical Trial Site Groton Connecticut
Clinical Trial Site Boynton Beach Florida 33426
Clinical Trial Site Boynton Beach Florida 33472
Clinical Trial Site Clearwater Florida 33756
Clinical Trial Site Clearwater Florida 33759
Clinical Trial Site Hialeah Florida
Clinical Trial Site Holiday Florida
Clinical Trial Site Inverness Florida
Clinical Trial Site Margate Florida
Clinical Trial Site Miami Florida 33126
Clinical Trial Site Miami Florida 33135
Clinical Trial Site Miami Florida 33143
Clinical Trial Site Miami Florida 33144
Clinical Trial Site Miami Florida 33175
Clinical Trial Site Miami Lakes Florida
Clinical Trial Site Naples Florida
Clinical Trial Site Vero Beach Florida
Clinical Trial Site West Palm Beach Florida
Clinical Trial Site Zephyrhills Florida
Clinical Trial Site Atlanta Georgia 30308
Clinical Trial Site Atlanta Georgia 30312
Clinical Trial Site Atlanta Georgia 30342
Clinical Trial Site Decatur Georgia
Clinical Trial Site Dublin Georgia
Clinical Trial Site Sandy Springs Georgia
Clinical Trial Site Stockbridge Georgia
Clinical Trial Site Aurora Illinois
Clinical Trial Site Chicago Illinois 60616
Clinical Trial Site Skokie Illinois 60076
Clinical Trial Site Skokie Illinois
Clinical Trial Site Springfield Illinois
Clinical Trial Site Wichita Kansas
Clinical Trial Site New Orleans Louisiana
Clinical Trial Site Bethesda Maryland
Clinical Trial Site Hollywood Maryland
Clinical Trial Site Bay City Michigan 48706
Clinical Trial Site Bay City Michigan
Clinical Trial Site Wyoming Michigan
Clinical Trial Site Kansas City Missouri
Clinical Trial Site Las Vegas Nevada
Clinical Trial Site Lawrenceville New Jersey
Clinical Trial Site Neptune City New Jersey
Clinical Trial Site Plainsboro New Jersey
Clinical Trial Site Voorhees Township New Jersey
Clinical Trial Site Albuquerque New Mexico
Clinical Trial Site Brooklyn New York
Clinical Trial Site New York New York 10038
Clinical Trial Site Raleigh North Carolina
Clinical Trial Site Winston-Salem North Carolina
Clinical Trial Site Canton Ohio
Clinical Trial Site Carlisle Ohio
Clinical Trial Site Cincinnati Ohio 45224
Clinical Trial Site Cincinnati Ohio 45242
Clinical Trial Site Columbus Ohio 43231
Clinical Trial Site Marion Ohio 43302
Clinical Trial Site Marion Ohio
Clinical Trial Site Mentor Ohio
Clinical Trial Site Middletown Ohio
Clinical Trial Site Zanesville Ohio
Clinical Trial Site Norman Oklahoma
Clinical Trial Site Jenkintown Pennsylvania
Clinical Trial Site Levittown Pennsylvania
Clinical Trial Site Columbia South Carolina
Clinical Trial Site Greer South Carolina
Clinical Trial Site Myrtle Beach South Carolina
Clinical Trial Site North Charleston South Carolina
Clinical Trial Site Rapid City South Dakota
Clinical Trial Site Arlington Texas
Clinical Trial Site Dallas Texas
Clinical Trial Site Houston Texas 77030
Clinical Trial Site Houston Texas 77074
Clinical Trial Site Houston Texas
Clinical Trial Site Laredo Texas
Clinical Trial Site Longview Texas
Clinical Trial Site San Antonio Texas 78205
Clinical Trial Site San Antonio Texas 78215
Clinical Trial Site San Antonio Texas 78229
Clinical Trial Site San Antonio Texas
Clinical Trial Site Orem Utah
Clinical Trial Site Chesapeake Virginia
Clinical Trial Site Norfolk Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01114217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01114217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →